• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电穿孔辅助将DNA疫苗递送至皮肤后引发的豚鼠T细胞反应的特征分析。

Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.

作者信息

Schultheis Katherine, Schaefer Hubert, Yung Bryan S, Oh Janet, Muthumani Karuppiah, Humeau Laurent, Broderick Kate E, Smith Trevor R F

机构信息

Inovio Pharmaceuticals, Inc., 660W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA.

Intracelluar Pathogens, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany.

出版信息

Vaccine. 2017 Jan 3;35(1):61-70. doi: 10.1016/j.vaccine.2016.11.052. Epub 2016 Nov 25.

DOI:10.1016/j.vaccine.2016.11.052
PMID:27894716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5221502/
Abstract

The skin is an ideal target tissue for vaccine delivery for a number of reasons. It is highly accessible, and most importantly, enriched in professional antigen presenting cells. Possessing strong similarities to human skin physiology and displaying a defined epidermis, the guinea pig is an appropriate model to study epidermal delivery of vaccine. However, whilst we have characterized the humoral responses in the guinea pig associated with skin vaccine protocols we have yet to investigate the T cell responses. In response to this inadequacy, we developed an IFN-γ ELISpot assay to characterize the cellular immune response in the peripheral blood of guinea pigs. Using a nucleoprotein (NP) influenza pDNA vaccination regimen, we characterized host T cell responses. After delivery of the DNA vaccine to the guinea pig epidermis we detected robust and rapid T cell responses. The levels of IFN-γ spot-forming units averaged approximately 5000 per million cells after two immunizations. These responses were broad in that multiple regions across the NP antigen elicited a T cell response. Interestingly, we identified a number of NP immunodominant T cell epitopes to be conserved across an outbred guinea pig population, a phenomenon which was also observed after immunization with a RSV DNA vaccine. We believe this data enhances our understanding of the cellular immune response elicited to a vaccine in guinea pigs, and globally, will advance the use of this model for vaccine development, especially those targeting skin as a delivery site.

摘要

出于多种原因,皮肤是疫苗递送的理想靶组织。它极易接近,最重要的是,富含专业抗原呈递细胞。豚鼠与人类皮肤生理学有很强的相似性,且表皮明确,是研究疫苗表皮递送的合适模型。然而,尽管我们已经对豚鼠中与皮肤疫苗方案相关的体液反应进行了表征,但我们尚未研究T细胞反应。针对这一不足,我们开发了一种IFN-γ ELISpot检测方法来表征豚鼠外周血中的细胞免疫反应。使用核蛋白(NP)流感pDNA疫苗接种方案,我们对宿主T细胞反应进行了表征。将DNA疫苗递送至豚鼠表皮后,我们检测到了强烈而快速的T细胞反应。两次免疫后,IFN-γ斑点形成单位的水平平均约为每百万细胞5000个。这些反应具有广泛性,因为NP抗原的多个区域都引发了T细胞反应。有趣的是,我们确定了一些NP免疫显性T细胞表位在远交豚鼠群体中是保守的,在用RSV DNA疫苗免疫后也观察到了这一现象。我们相信,这些数据增强了我们对豚鼠疫苗引发的细胞免疫反应的理解,并且在全球范围内,将推动该模型在疫苗开发中的应用,尤其是那些以皮肤作为递送部位的疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/93e278281a4b/nihms838001f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/5a0d431c609e/nihms838001f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/89b4eaf62bb0/nihms838001f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/6659de374a6f/nihms838001f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/f057bfbf3029/nihms838001f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/1c17c0e9218f/nihms838001f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/93e278281a4b/nihms838001f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/5a0d431c609e/nihms838001f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/89b4eaf62bb0/nihms838001f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/6659de374a6f/nihms838001f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/f057bfbf3029/nihms838001f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/1c17c0e9218f/nihms838001f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a3/5221502/93e278281a4b/nihms838001f6.jpg

相似文献

1
Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.电穿孔辅助将DNA疫苗递送至皮肤后引发的豚鼠T细胞反应的特征分析。
Vaccine. 2017 Jan 3;35(1):61-70. doi: 10.1016/j.vaccine.2016.11.052. Epub 2016 Nov 25.
2
Novel IFN-γ ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.新型 IFN-γ ELISpot 揭示了新西兰白兔流感核蛋白 DNA 疫苗接种后引发的强大 T 细胞反应。
Vaccine. 2019 Feb 8;37(7):903-909. doi: 10.1016/j.vaccine.2019.01.006. Epub 2019 Jan 17.
3
A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.一种新型的电穿孔增强型 DNA 疫苗递药装置,可同时递送至皮肤和肌肉。
Vaccine. 2011 Sep 9;29(39):6771-80. doi: 10.1016/j.vaccine.2010.12.057. Epub 2011 Jan 1.
4
Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination.优化的干扰素-γ酶联免疫斑点试验用于测量豚鼠模型接种疫苗后的T细胞反应。
J Vis Exp. 2019 Jan 20(143). doi: 10.3791/58595.
5
Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.电穿孔介导的 DNA 疫苗直接接种到黏膜表面可提高免疫应答。
Hum Vaccin Immunother. 2013 Oct;9(10):2041-8. doi: 10.4161/hv.25272. Epub 2013 Jun 11.
6
Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.流感病毒囊泡/DNA 疫苗复合物作为一种新配方,可诱导针对流感病毒挑战的亚型内保护。
Antiviral Res. 2012 Sep;95(3):229-36. doi: 10.1016/j.antiviral.2012.07.003. Epub 2012 Jul 15.
7
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.新型微创电穿孔仪的样机研制与临床前免疫原性分析。
Gene Ther. 2011 Mar;18(3):258-65. doi: 10.1038/gt.2010.137. Epub 2010 Oct 21.
8
Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.新型 HCV 基因 1a/1b 型共有 DNA 疫苗在恒河猴体内诱导产生的强烈 HCV NS3/4a、NS4b、NS5a、NS5b 特异性细胞免疫应答。
Hum Vaccin Immunother. 2014;10(8):2357-65. doi: 10.4161/hv.29590.
9
Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.用编码与组织纤溶酶原激活剂信号序列融合的甲型流感病毒核蛋白的质粒DNA进行免疫接种,可在小鼠体内引发强烈的免疫反应并提供针对H5N1攻击的保护。
J Virol Methods. 2008 Dec;154(1-2):121-7. doi: 10.1016/j.jviromet.2008.08.011. Epub 2008 Sep 27.
10
Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine.新型豚鼠特异性干扰素-γ酶联免疫斑点试验的开发以及用安卡拉痘苗病毒(MVA)载体GP83疫苗免疫后豚鼠巨细胞病毒GP83特异性细胞免疫反应的特征分析
Vaccine. 2014 Jun 30;32(31):3963-70. doi: 10.1016/j.vaccine.2014.05.011. Epub 2014 May 20.

引用本文的文献

1
Intradermal DNA vaccine delivery using vacuum-controlled, needle-free electroporation.使用真空控制的无针电穿孔进行皮内DNA疫苗递送。
Mol Ther Nucleic Acids. 2023 Oct 31;34:102070. doi: 10.1016/j.omtn.2023.102070. eCollection 2023 Dec 12.
2
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models.临床前动物模型中 DNA 和 mRNA COVID-19 疫苗诱导的免疫反应的描绘。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2281733. doi: 10.1080/21645515.2023.2281733. Epub 2023 Nov 27.
3
A Simple and Efficient Genetic Immunization Protocol for the Production of Highly Specific Polyclonal and Monoclonal Antibodies against the Native Form of Mammalian Proteins.

本文引用的文献

1
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.由主要组织相容性复合体E限制的广泛靶向性CD8⁺T细胞反应
Science. 2016 Feb 12;351(6274):714-20. doi: 10.1126/science.aac9475. Epub 2016 Jan 21.
2
Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.阐明由表面真皮电穿孔增强的质粒基因递送所导致的表达动力学和免疫细胞浸润。
Vaccines (Basel). 2013 Aug 28;1(3):384-97. doi: 10.3390/vaccines1030384.
3
A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals.
一种简单高效的遗传免疫方案,用于生产针对天然形式的哺乳动物蛋白的高特异性多克隆和单克隆抗体。
Int J Mol Sci. 2020 Sep 25;21(19):7074. doi: 10.3390/ijms21197074.
4
Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.肠毒素性大肠杆菌 CFA/I 黏附素-不耐热肠毒素嵌合体的免疫原性和保护效力评估。
Infect Immun. 2020 Oct 19;88(11). doi: 10.1128/IAI.00252-20.
5
Protection against infection mediated by a synthetically engineered DNA vaccine.合成工程化 DNA 疫苗介导的抗感染保护。
Hum Vaccin Immunother. 2020 Sep 1;16(9):2114-2122. doi: 10.1080/21645515.2020.1789408. Epub 2020 Aug 12.
6
Immunogenicity of a DNA vaccine candidate for COVID-19.针对 COVID-19 的 DNA 疫苗候选物的免疫原性。
Nat Commun. 2020 May 20;11(1):2601. doi: 10.1038/s41467-020-16505-0.
7
Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4 and CD8 T Cells Associated with Protection against Recurrent Genital Herpes.用核昔酸还原酶 2(RR2)蛋白对感染单纯疱疹病毒 2 的豚鼠进行治疗性黏膜疫苗接种,可增强抗病毒中和抗体和局部组织驻留的 CD4 和 CD8 T 细胞,从而预防复发性生殖器疱疹。
J Virol. 2019 Apr 17;93(9). doi: 10.1128/JVI.02309-18. Print 2019 May 1.
8
A Review of DNA Vaccines Against Influenza.抗流感DNA疫苗综述。
Front Immunol. 2018 Jul 9;9:1568. doi: 10.3389/fimmu.2018.01568. eCollection 2018.
9
Adipose tissue: a new target for electroporation-enhanced DNA vaccines.脂肪组织:电穿孔增强型 DNA 疫苗的新靶点。
Gene Ther. 2017 Dec;24(12):757-767. doi: 10.1038/gt.2017.96. Epub 2017 Nov 6.
10
Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods.针对呼吸道合胞病毒的核酸疫苗:交付货物。
Hum Vaccin Immunother. 2017 Nov 2;13(11):2626-2629. doi: 10.1080/21645515.2017.1363134.
一种减毒活疫苗可预防H7N9病毒在哺乳动物体内的复制和传播。
Sci Rep. 2015 Jun 10;5:11233. doi: 10.1038/srep11233.
4
DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response.DNA 疫苗接种策略靶向表皮树突状细胞,启动其迁移并诱导宿主免疫反应。
Mol Ther Methods Clin Dev. 2014 Dec 3;1:14054. doi: 10.1038/mtm.2014.54. eCollection 2014.
5
Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine.新型豚鼠特异性干扰素-γ酶联免疫斑点试验的开发以及用安卡拉痘苗病毒(MVA)载体GP83疫苗免疫后豚鼠巨细胞病毒GP83特异性细胞免疫反应的特征分析
Vaccine. 2014 Jun 30;32(31):3963-70. doi: 10.1016/j.vaccine.2014.05.011. Epub 2014 May 20.
6
Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.CELLECTRA(®)自适应恒流电穿孔仪经肌肉和皮内给药在健康志愿者中的耐受性。
Hum Vaccin Immunother. 2013 Oct;9(10):2246-52. doi: 10.4161/hv.24702. Epub 2013 Jun 4.
7
Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.保护性 DNA 疫苗接种诱导针对马尔堡和埃博拉的广谱细胞毒性 T 细胞。
Mol Ther. 2013 Jul;21(7):1432-44. doi: 10.1038/mt.2013.61. Epub 2013 May 14.
8
Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.使用微创表面装置优化电穿孔增强DNA疫苗皮内递送
Hum Gene Ther Methods. 2012 Jun;23(3):157-68. doi: 10.1089/hgtb.2011.209. Epub 2012 Jul 13.
9
Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults.健康成年人中 Easy Vax™ 临床表皮电穿孔系统的安全性和耐受性。
Mol Ther. 2012 Jan;20(1):214-20. doi: 10.1038/mt.2011.235. Epub 2011 Nov 8.
10
T-cell-inducing vaccines - what's the future.T 细胞诱导疫苗——未来如何。
Immunology. 2012 Jan;135(1):19-26. doi: 10.1111/j.1365-2567.2011.03517.x.